| 1 |
Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastro-enterology, 2004, 127(5 Suppl 1): S5-S16.
|
| 2 |
邹声泉. 胆汁蛋白质组研究筛选胆道肿瘤早期诊断标志物的意义. 外科理论与实践, 2009, 14(2): 132-134.
|
| 3 |
Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis, 2004, 24(2): 139-154.
|
| 4 |
Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangio-carcinoma: 1990-2009. World J Gastroenterol, 2009, 15(34): 4240-4262.
|
| 5 |
Kristiansen TZ, Bunkenborg J, Gronborg M, et al. A proteomic analysis of human bile. Mol Cell Proteomics,2004,3(7):715-728.
|
| 6 |
Koopmann J, Thuluvath PJ, Zahurak ML, et al. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer, 2004, 101(7): 1609-1615.
|
| 7 |
Farid SG, Craven RA, Peng J, et al. Shotgun proteomics of human bile in hilar cholangiocarcinoma. Proteomics, 2011, 11(10): 2134-2138.
|
| 8 |
Chen B, Dong JQ, Chen YJ, et al. Two-dimensional electrophoresis for comparative proteomic analysis of human bile. Hepatobiliary Pancreat Dis Int, 2007, 6(4): 402-406.
|
| 9 |
黄国飞，王济明，罗诗樵, 等. 人胆管癌与正常人胆汁蛋白质组学研究. 中国癌症杂志, 2009, 19(2): 106-111.
|
| 10 |
陈波，郑建伟，王剑明, 等. 人胆汁蛋白质组双向电泳图谱的建立与初步分析. 中华肝胆外科杂志, 2007, 13(8): 536-539.
|
| 11 |
陈波，刘小方，邹声泉, 等. 人胆汁蛋白质组双向荧光差异凝胶电泳图谱的建立与差异分析.中华实验外科杂志, 2008, 25(4): 466-468.
|
| 12 |
陈波，邹声泉，邱江锋, 等. 荧光差异凝胶电泳筛选胆管癌胆汁差异表达蛋白的研究. 中华肝胆外科杂志, 2011, 17(3): 231-234.
|
| 13 |
沈健. 人胆汁中潜在的胆管癌肿瘤标志物的筛选及相关蛋白的功能研究. 南京: 南京医科大学, 2012.
|
| 14 |
Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 2011, 61(4): 212-236.
|
| 15 |
Colombo M. Screening for cancer in viral hepatitis. Clin Liver Dis, 2001, 5(1): 109-122.
|
| 16 |
吕有勇，邢蕊. 肿瘤形成的理论假说与未来临床诊疗策略[J/CD]. 中华普通外科学文献:电子版, 2012, 6(1): 1-5.
|
| 17 |
Yeo M, Na YM, Kim DK, et al. The loss of phenol sulfotransferase 1 in hepatocellular carcinogenesis. Proteomics, 2010, 10(2): 266-276.
|
| 18 |
Na K, Lee EY, Lee HJ, et al. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics, 2009, 9(16): 3989-3999.
|
| 19 |
蒋智华，张志勇，何敏, 等. 应用蛋白质组学技术筛检肝癌血清差异蛋白质并分离鉴定阿朴脂蛋白AⅡ. 中华肝脏病杂志, 2010, 18(6): 445-449.
|
| 20 |
Kimura A, Sogawa K, Satoh M, et al. The application of a three-step serum proteome analysis for the discovery and identification of novel biomarkers of hepatocellular carcinoma. Int J Proteomics, 2012, 2012(6): 623190.
|
| 21 |
Zinkin NT, Grall F, Bhaskar K, et al. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res, 2008, 14(2): 470-477.
|